Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MRKR Marker Therapeutics > Detailed Quotes

MRKR Marker Therapeutics

0.341
+0.007+2.10%
Trading Session 09/27 14:04 ET
High
0.360
Open
0.341
Turnover
23.86K
Low
0.330
Pre Close
0.334
Volume
69.65K
Market Cap
28.47M
P/E(TTM)
Loss
52wk High
1.730
Shares
83.60M
P/E(Static)
Loss
52wk Low
0.250
Float Cap
20.36M
Bid/Ask %
50.00%
Historical High
244.800
Shs Float
59.78M
Volume Ratio
0.51
Historical Low
0.074
Dividend TTM
--
Div Yield TTM
--
P/B
1.02
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.12%
Amplitude
8.82%
Avg Price
0.342
Lot Size
1
Float Cap
20.36M
Bid/Ask %
50.00%
Historical High
244.800
Shs Float
59.78M
Volume Ratio
0.51
Historical Low
0.074
Dividend TTM
--
P/B
1.02
Dividend LFY
--
Turnover Ratio
0.12%
Amplitude
8.82%
Avg Price
0.342
Lot Size
1
Price Forecast

No Data

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
CEO: Mr. Peter L. Hoang
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...